Emile Voest
Directeur/Membre du Conseil chez SANOFI
Postes actifs de Emile Voest
Sociétés | Poste | Début | Fin |
---|---|---|---|
SANOFI | Directeur/Membre du Conseil | 03/05/2022 | - |
Independent Dir/Board Member | 03/05/2022 | - | |
Hartwig Medical Foundation | Directeur/Membre du Conseil | 01/01/2015 | - |
Fondateur | 01/01/2015 | - | |
Center For Personalized Cancer Therapy | Directeur/Membre du Conseil | 01/01/2010 | - |
Fondateur | 01/01/2010 | - | |
University of Utrecht | Corporate Officer/Principal | 01/01/1999 | - |
Historique de carrière de Emile Voest
Anciens postes connus de Emile Voest
Sociétés | Poste | Début | Fin |
---|---|---|---|
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Directeur Technique/Scientifique/R&D | 01/01/2014 | 01/01/2020 |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Directeur/Membre du Conseil | 01/01/2015 | 01/01/2020 |
Hubrecht Organoid Technology Foundation | Directeur Technique/Scientifique/R&D | 01/01/2013 | 01/01/2016 |
Fondateur | 01/01/2013 | 01/01/2016 |
Formation de Emile Voest
University of Utrecht | Doctorate Degree |
Statistiques
Internationale
Pays-Bas | 5 |
France | 2 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 4 |
Founder | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
Miscellaneous | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SANOFI | Health Technology |
Entreprise privées | 5 |
---|---|
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Miscellaneous |
Hartwig Medical Foundation | |
Center For Personalized Cancer Therapy | |
Hubrecht Organoid Technology Foundation | |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Health Services |
- Bourse
- Insiders
- Emile Voest
- Expérience